Mar 05, 2024
Posted by: Raffaello Sbordoni
Antibody-drug conjugates (ADCs) target cancer cells while reducing harm to healthy tissue. However, off-target toxicity remains a concern, demanding thorough evaluation. Read this blog post to explore the role of advanced in vitro models for toxicity screening of ADCs.
Jan 14, 2023
Posted by: Raffaello Sbordoni
Discover 5 essential tips for designing and setting up a complex in vitro model (CIVM) that mimics the human body more effectively than traditional models. From maximizing cell types to validating your model, these insights will help you advance your research and increase its relevance
Jun 25, 2020
Posted by: Valon Llabjani
Discover the current state of the art in organ-on-a-chip technologies and how they compare to conventional cell culture methods. Dr. Valon Llabjani, Founder and CEO of Revivocell Limited, explores the advancements, limitations, and the need for improved models. Learn about Revivocell's CELLBLOKS® technology, a modular multi-organ/cell type co-culture system that bridges the gap between traditional methods and organs-on-a-chip approaches.
